IL324996A - שיטות להערכה וניהול של חולי סרטן שלפוחית השתן - Google Patents
שיטות להערכה וניהול של חולי סרטן שלפוחית השתןInfo
- Publication number
- IL324996A IL324996A IL324996A IL32499625A IL324996A IL 324996 A IL324996 A IL 324996A IL 324996 A IL324996 A IL 324996A IL 32499625 A IL32499625 A IL 32499625A IL 324996 A IL324996 A IL 324996A
- Authority
- IL
- Israel
- Prior art keywords
- subject
- risk
- seq
- bcg
- score
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/07—Bacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
- A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IL2023/050564 WO2024246882A1 (en) | 2023-05-31 | 2023-05-31 | Methods for evaluating and managing bladder cancer patients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL324996A true IL324996A (he) | 2026-01-01 |
Family
ID=93656841
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL324996A IL324996A (he) | 2023-05-31 | 2023-05-31 | שיטות להערכה וניהול של חולי סרטן שלפוחית השתן |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP4720346A1 (he) |
| IL (1) | IL324996A (he) |
| WO (1) | WO2024246882A1 (he) |
-
2023
- 2023-05-31 IL IL324996A patent/IL324996A/he unknown
- 2023-05-31 EP EP23939447.1A patent/EP4720346A1/en active Pending
- 2023-05-31 WO PCT/IL2023/050564 patent/WO2024246882A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP4720346A1 (en) | 2026-04-08 |
| WO2024246882A1 (en) | 2024-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2022221408B2 (en) | Methods for diagnosing bladder cancer | |
| JP5378687B2 (ja) | Basp1遺伝子および/またはsrd5a2遺伝子中のメチル化シトシンを利用する、肝臓癌、肝臓癌発症リスク、肝臓癌再発リスク、肝臓癌悪性度および肝臓癌の経時的進展の検出方法 | |
| JP2022525890A (ja) | Dna試料のメチル化変化を検出するための方法およびシステム | |
| US20090047656A1 (en) | Molecular analysis of primary cells | |
| US20170121775A1 (en) | Detection and Prognosis of Lung Cancer | |
| AU2025226734A1 (en) | Kits and Methods for Diagnosing Lung Cancer | |
| Khongsti et al. | Whole genome DNA methylation profiling of oral cancer in ethnic population of Meghalaya, North East India reveals novel genes | |
| Shaw et al. | CpG island methylation phenotype (CIMP) in oral cancer: associated with a marked inflammatory response and less aggressive tumour biology | |
| US20240093302A1 (en) | Non-invasive cancer detection based on dna methylation changes | |
| US20250092461A1 (en) | Personalized cancer management and monitoring based on dna methylation changes in cell-free dna | |
| JP2011509688A (ja) | 前立腺癌におけるgstp1高メチル化の発見 | |
| WO2017119510A1 (ja) | 乳がんの診断のための検査方法、遺伝子マーカー、および検査薬 | |
| IL324996A (he) | שיטות להערכה וניהול של חולי סרטן שלפוחית השתן | |
| WO2023116593A1 (zh) | 一种肿瘤检测方法及应用 | |
| CN114908166A (zh) | 一组与结直肠癌相关的特异性甲基化标志物及其检测试剂盒 | |
| WO2024176212A1 (en) | Assessment of hematuria and other urinary tract symptoms | |
| WO2025033530A1 (ja) | 大腸癌の診断マーカー | |
| HK40105151A (en) | Methods for diagnosing bladder cancer | |
| KR20250086607A (ko) | 전립선암의 진단을 위한 신규 rna 바이오마커 | |
| CN120210361A (zh) | 一种胆管癌甲基化标志物、胆管癌检测试剂盒及应用 | |
| HK40009937A (en) | Methods for diagnosing lung cancer | |
| HK1249144A1 (en) | Methods for diagnosing bladder cancer |